Ultra performance liquid chromatographic method for simultaneous quantification of plerixafor and related substances in an injection formulation

References

• Calandra, G., McCarty, J., McGuirk, J., Tricot, G., Crocker, S. A., Badel, K., ... Bridger, G. (2008). AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin’s disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: Compassionate use data. Bone Marrow Transplantation, 41, 1–15.10.1038/sj.bmt.1705908
   Google Scholar
• CHMP Assessment Report. (2009). Retrieved from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/001030/WC500030689.pdf
   Google Scholar
• Devine, S. M., Vij, R., Rettig, M., Todt, L., McGlauchlen, K., Fisher, N., ... Westervelt, P. (2008, August 15). Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood, 112, 990–998.10.1182/blood-2007-12-130179
   Google Scholar
• DiPersio, J. F., Micallef, I., Stiff, P. J., Bolwell, B. J., Maziarz, R. T., Angell, J., ... Calandra, G. (2007, November 16). A phase III, multicenter, randomized, double-blind, placebo controlled, comparative trial of AMD3100 (plerixafor)+G-CSF vs. placebo+G-CSF in non-Hodgkin’s lymphoma patients forautologous hematopoietic stem cell (aHSC) transplantation (Abstract No. 601). Blood, 110, 185a.
   Google Scholar
• DiPersio J., Stadtmauer E. A., Nademanee A. P., Stiff, P., Micallef, I., Angell, J., … Calandra, G. (2007, November 16). A phase III, multicenter, randomized, double-blind, placebocontrolled, comparative trial of AMD3100 (plerixafor)+GCSF vs. G-CSF+placebo for mobilization in multiple myeloma (MM) patients for autologous hematopoietic stem cell (aHSC) transplantation (Abstract No. 445). Blood, 110, 137–138a.
   Google Scholar
• Drug Bank. (2010). Retrieved from http://www.drugbank.ca/drugs/DB06809
   Google Scholar
• Drugs at FDA. (2008). Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf
   Google Scholar
• Fanali, S., Haddad, P., Poole, C., Schoenmakers, P., & Lloyd, D. (2013). Liquid chromatography. Waltham, MA: Elsevier.
   Google Scholar
• Flomenberg, N., Devine, S. M., DiPersio, J. F., Liesveld, J. L., McCarty, J. M., Rowley, S. D., ... Calandra, G. (2005, September 1). The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood, 106, 1867–1874.10.1182/blood-2005-02-0468
   Google Scholar
• Gerlach, L. O., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2001, April 27). Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. Journal of Biological Chemistry, 276, 14153–14160.
   Google Scholar
• Hanimi Reddy, B., Ravi Kumar, M., & Satyanarayana Murthy, R. (2015). Robust and rugged stability- indicating HPLC method for the determination of plerixafor and its related impurities in drug substances. Journal of Chromatographic Science, 53, 1432–1442. doi:10.1093/chromsci/bmv029
   Google Scholar
• Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002, September 1). Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Letters, 527, 255–262.10.1016/S0014-5793(02)03143-5
   Google Scholar
• Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., ... Henson, G. W. (2000, June). Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrobial Agents and Chemotherapy, 44, 1667–1673.10.1128/AAC.44.6.1667-1673.2000
   Google Scholar
• Hess, D. A., Bonde, J., Craft, T. C., Wirthlin, L., Hohm, S., Lahey, R., Nolta, J. A. (2007, April). Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biology of Blood and Marrow Transplantation, 13, 398–411.10.1016/j.bbmt.2006.12.445
   Google Scholar
• Hübel, K., Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B., Cooper, S., ... Calandra, G. (2004, April 1). Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist. Supportive Cancer Therapy, 1, 165–172.10.3816/SCT.2004.n.008
   Google Scholar
• Klocke, R., Kuhlmann, M. T., Scobioala, S., Schabitz, W. R., & Nikol, S. (2008). Granulocytecolony-stimulating factor (G-CSF) for cardio- andcerebrovascular regenerative applications. Current Medicinal Chemistry, 15, 968–977.
   Google Scholar
• Lack, N. A., Green, B., Dale, D. C., Calandra, G. B., Lee, H., MacFarland, R. T., ... Bridger, G. (2005, May). A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100. Clinical Pharmacology & Therapeutics, 77, 427–436.10.1016/j.clpt.2004.12.268
   Google Scholar
• MacFarland R., Ewesuedo R. B., Badel K., & Calandra G. (2007, November 16). Pharmacokinetics of plerixafor (AMD3100) in volunteers with renal impairment (Abstract No. 2878). Blood, 110, 847a.
   Google Scholar
• Mathrusri Annapurna, M., Sai Pavan Kumar, B., Goutam, S. V. S., & Venkatesh, B. (2012). Stability-indicating high performance liquid chromatographic and derivative spectrophotometric methods for Plerixafor. Drug Invention Today, 4, 465–469.
   Google Scholar
• Montgomery, M., & Cottler-Fox, M. (2007, February). Mobilization and collectionof autologous hematopoietic progenitor/stem cells. Clinical Advances in Hematology and Oncology, 5, 127–136.
   Google Scholar
• Mozobil. (2016). Retrieved from http://www.rxlist.com/mozobil-drug.htm
   Google Scholar
• Mozobil, Genzyme Corporation. (2015). Retrieved from http://www.mozobil.com
   Google Scholar
• Q2A (R1) validation of analytical procedures: Text and methodology, international conference on harmonization. 2005.
   Google Scholar
• Rosenkilde, M. M., Gerlach, L. O., Jakobsen, J. S., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2004, January 23). Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor. Journal of Biological Chemistry, 279, 3033–3041.10.1074/jbc.M309546200
   Google Scholar
• Verpoorte, R., & Baerheim, S. (1984). Chromatography of alkaloids. Amsterdam: Elsevier.
   Google Scholar